Distinct cell-specific control of autoimmunity and infection by FcγRIIb
Loading...
Download
Associated Records
File Licence
Editors
Date
2008-04-14
Source Title
Journal of Experimental Medicine (JEM)
Journal Title
Journal ISSN
Volume Title
Publisher
ROCKEFELLER UNIV PRESS
Melbourne Authors
Affiliation
Medical Biology (W.E.H.I.)
Document Type
Journal Article
Subject Code
Citation
Brownlie, R. J., Lawlor, K. E., Niederer, H. A., Cutler, A. J., Xiang, Z., Clatworthy, M. R., Floto, R. A., Greaves, D. R., Lyons, P. A. & Smith, K. G. C. (2008). Distinct cell-specific control of autoimmunity and infection by FcγRIIb. Journal of Experimental Medicine, 205 (4), pp.883-895. https://doi.org/10.1084/jem.20072565.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
FcgammaRIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important in controlling responses to infection, and reduced expression or function predisposes to autoimmunity. To determine if increased expression of FcgammaRIIb can modulate these processes, we created transgenic mice overexpressing FcgammaRIIb on B cells or macrophages. Overexpression of FcgammaRIIb on B cells reduced the immunoglobulin G component of T-dependent immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneous systemic lupus erythematosus (SLE). In contrast, overexpression on macrophages had no effect on immune responses, CIA, or SLE but increased mortality after Streptococcus pneumoniae infection. These results help define the role of FcgammaRIIb in immune responses, demonstrate the contrasting roles played by FcgammaRIIb on B cells and macrophages in the control of infection and autoimmunity, and emphasize the therapeutic potential for modulation of FcgammaRIIb expression on B cells in inflammatory and autoimmune disease.